Several studies published Wednesday supporting potential use of Pfizer’s COVID-19 vaccine booster shot amid waning immunity met a neutral tone from the Food and Drug Administration, per documents posted ahead of a critical meeting Friday.
Several studies published Wednesday supporting potential use of Pfizer’s COVID-19 vaccine booster shot amid waning immunity met a neutral tone from the Food and Drug Administration, per documents posted ahead of a critical meeting Friday.